# Avalon Holdings Corp: financial statements, quarterly

AWX · NYSE · CIK 1061069 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/awx.md) · [Financials](/companies/awx/financials.md) · [Filings](/companies/awx/filings.md) · [Insiders](/companies/awx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/awx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [23.9](/filings/0001437749-24-034232.md) | [17.7 d](/filings/0001437749-25-008584.md) | [18.9](/filings/0001437749-25-015162.md) | [23.1](/filings/0001437749-25-025765.md) | [24.2](/filings/0001437749-25-033887.md) | [17.6 d](/filings/0001437749-26-009091.md) | [16.1](/filings/0001437749-26-014934.md) | [20.3](/filings/0001437749-26-026609.md) | [25.7](/filings/0001437749-25-033887.md) | [21.5 d](/filings/0001437749-26-009091.md) | [17.7](/filings/0001437749-26-014934.md) | [20.9](/filings/0001437749-26-026609.md) |
| Cost of revenue | $m | not reported | not reported | [15.8](/filings/0001437749-25-015162.md) | [18.0](/filings/0001437749-25-025765.md) | [18.3](/filings/0001437749-25-033887.md) | [14.6 d](/filings/0001437749-26-009091.md) | [13.7](/filings/0001437749-26-014934.md) | [16.1](/filings/0001437749-26-026609.md) | [19.6](/filings/0001437749-25-033887.md) | [17.8 d](/filings/0001437749-26-009091.md) | [14.8](/filings/0001437749-26-014934.md) | [16.0](/filings/0001437749-26-026609.md) |
| Selling, general and administrative | $m | [2.8](/filings/0001437749-24-034232.md) | [2.4 d](/filings/0001437749-25-008584.md) | [2.6](/filings/0001437749-25-015162.md) | [2.7](/filings/0001437749-25-025765.md) | [2.7](/filings/0001437749-25-033887.md) | [2.3 d](/filings/0001437749-26-009091.md) | [2.6](/filings/0001437749-26-014934.md) | [2.5](/filings/0001437749-26-026609.md) | [2.8](/filings/0001437749-25-033887.md) | [2.7 d](/filings/0001437749-26-009091.md) | [2.7](/filings/0001437749-26-014934.md) | [2.6](/filings/0001437749-26-026609.md) |
| Operating income | $m | [1.4](/filings/0001437749-24-034232.md) | [(0.3) d](/filings/0001437749-25-008584.md) | [(0.5)](/filings/0001437749-25-015162.md) | [1.4](/filings/0001437749-25-025765.md) | [2.3](/filings/0001437749-25-033887.md) | [(0.1) d](/filings/0001437749-26-009091.md) | [(1.2)](/filings/0001437749-26-014934.md) | [0.8](/filings/0001437749-26-026609.md) | [2.3](/filings/0001437749-25-033887.md) | [0.1 d](/filings/0001437749-26-009091.md) | [(0.7)](/filings/0001437749-26-014934.md) | [1.4](/filings/0001437749-26-026609.md) |
| Interest expense | $m | [0.5](/filings/0001437749-23-031315.md) | [0.5 d](/filings/0001437749-24-008877.md) | [0.5](/filings/0001437749-25-015162.md) | [0.5](/filings/0001437749-25-025765.md) | [0.5](/filings/0001437749-25-033887.md) | [0.5 d](/filings/0001437749-26-009091.md) | [0.5](/filings/0001437749-26-014934.md) | [0.5](/filings/0001437749-26-026609.md) | [0.5](/filings/0001437749-25-033887.md) | [0.5 d](/filings/0001437749-26-009091.md) | [0.5](/filings/0001437749-26-014934.md) | [0.5](/filings/0001437749-26-026609.md) |
| Income tax | $m | [0.0](/filings/0001437749-24-034232.md) | [(0.0) d](/filings/0001437749-25-008584.md) | [0.0](/filings/0001437749-25-015162.md) | [0.0](/filings/0001437749-25-025765.md) | [0.0](/filings/0001437749-25-033887.md) | [(0.0) d](/filings/0001437749-26-009091.md) | [0.0](/filings/0001437749-26-014934.md) | [0.0](/filings/0001437749-26-026609.md) | [0.0](/filings/0001437749-25-033887.md) | [(0.0) d](/filings/0001437749-26-009091.md) | [0.0](/filings/0001437749-26-014934.md) | [0.0](/filings/0001437749-26-026609.md) |
| Net income | $m | [0.9](/filings/0001437749-24-034232.md) | [(0.8) d](/filings/0001437749-25-008584.md) | [(1.0)](/filings/0001437749-25-015162.md) | [1.0](/filings/0001437749-25-025765.md) | [1.8](/filings/0001437749-25-033887.md) | [(0.5) d](/filings/0001437749-26-009091.md) | [(1.5)](/filings/0001437749-26-014934.md) | [0.3](/filings/0001437749-26-026609.md) | [1.9](/filings/0001437749-25-033887.md) | [(0.4) d](/filings/0001437749-26-009091.md) | [(1.2)](/filings/0001437749-26-014934.md) | [0.9](/filings/0001437749-26-026609.md) |
| Diluted EPS | $ per share | [0.23](/filings/0001437749-23-031315.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.23](/filings/0001437749-24-034232.md) | not reported | [(0.25)](/filings/0001437749-25-015162.md) | [0.24](/filings/0001437749-25-025765.md) | [0.47](/filings/0001437749-25-033887.md) | not reported | [(0.38)](/filings/0001437749-26-014934.md) | [0.07](/filings/0001437749-26-026609.md) | [0.49](/filings/0001437749-25-033887.md) | not reported | [(0.32)](/filings/0001437749-26-014934.md) | [0.23](/filings/0001437749-26-026609.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.7](/filings/0001437749-23-031315.md) | [1.2](/filings/0001437749-25-008584.md) | [1.2](/filings/0001437749-24-015406.md) | [3.8](/filings/0001437749-24-025598.md) | [3.9](/filings/0001437749-24-034232.md) | [2.8](/filings/0001437749-26-009091.md) | [1.3](/filings/0001437749-25-015162.md) | [3.7](/filings/0001437749-25-025765.md) | [4.6](/filings/0001437749-25-033887.md) | [4.1](/filings/0001437749-26-026609.md) | [2.4](/filings/0001437749-26-014934.md) | [4.8](/filings/0001437749-26-026609.md) |
| Current assets | $m | [15.8](/filings/0001437749-23-031315.md) | [14.0](/filings/0001437749-25-008584.md) | [17.4](/filings/0001437749-24-015406.md) | [19.2](/filings/0001437749-24-025598.md) | [17.2](/filings/0001437749-24-034232.md) | [14.6](/filings/0001437749-26-009091.md) | [16.3](/filings/0001437749-25-015162.md) | [17.3](/filings/0001437749-25-025765.md) | [20.2](/filings/0001437749-25-033887.md) | [17.0](/filings/0001437749-26-026609.md) | [17.7](/filings/0001437749-26-014934.md) | [18.5](/filings/0001437749-26-026609.md) |
| Total assets | $m | [90.0](/filings/0001437749-23-031315.md) | [88.0](/filings/0001437749-25-008584.md) | [90.6](/filings/0001437749-24-015406.md) | [91.7](/filings/0001437749-24-025598.md) | [89.1](/filings/0001437749-24-034232.md) | [86.2](/filings/0001437749-26-009091.md) | [87.6](/filings/0001437749-25-015162.md) | [88.1](/filings/0001437749-25-025765.md) | [90.7](/filings/0001437749-25-033887.md) | [87.4](/filings/0001437749-26-026609.md) | [87.5](/filings/0001437749-26-014934.md) | [87.6](/filings/0001437749-26-026609.md) |
| Current liabilities | $m | [20.1](/filings/0001437749-23-031315.md) | [17.9](/filings/0001437749-25-008584.md) | [21.8](/filings/0001437749-24-015406.md) | [22.2](/filings/0001437749-24-025598.md) | [17.7](/filings/0001437749-24-034232.md) | [15.5](/filings/0001437749-26-009091.md) | [18.6](/filings/0001437749-25-015162.md) | [18.9](/filings/0001437749-25-025765.md) | [19.9](/filings/0001437749-25-033887.md) | [16.8](/filings/0001437749-26-026609.md) | [18.5](/filings/0001437749-26-014934.md) | [18.1](/filings/0001437749-26-026609.md) |
| Long-term debt | $m | [29.4](/filings/0001437749-23-031315.md) | [29.2](/filings/0001437749-25-008584.md) | [29.1](/filings/0001437749-24-015406.md) | [28.9](/filings/0001437749-24-025598.md) | [28.8](/filings/0001437749-24-034232.md) | [28.6](/filings/0001437749-26-009091.md) | [28.5](/filings/0001437749-25-015162.md) | [28.3](/filings/0001437749-25-025765.md) | [28.2](/filings/0001437749-25-033887.md) | [28.0](/filings/0001437749-26-026609.md) | [27.9](/filings/0001437749-26-014934.md) | [27.7](/filings/0001437749-26-026609.md) |
| Current portion of debt | $m | [0.5](/filings/0001437749-23-031315.md) | [0.5](/filings/0001437749-25-008584.md) | [0.5](/filings/0001437749-24-015406.md) | [0.6](/filings/0001437749-24-025598.md) | [0.6](/filings/0001437749-24-034232.md) | [0.6](/filings/0001437749-26-009091.md) | [0.6](/filings/0001437749-25-015162.md) | [0.6](/filings/0001437749-25-025765.md) | [0.6](/filings/0001437749-25-033887.md) | [0.6](/filings/0001437749-26-026609.md) | [0.6](/filings/0001437749-26-014934.md) | [0.6](/filings/0001437749-26-026609.md) |
| Shareholders' equity | $m | [37.5](/filings/0001437749-23-031315.md) | [36.7](/filings/0001437749-25-008584.md) | [35.7](/filings/0001437749-24-015406.md) | [36.7](/filings/0001437749-24-025598.md) | [38.5](/filings/0001437749-24-034232.md) | [38.0](/filings/0001437749-26-009091.md) | [36.5](/filings/0001437749-25-015162.md) | [36.8](/filings/0001437749-25-025765.md) | [38.7](/filings/0001437749-25-033887.md) | [38.4](/filings/0001437749-26-026609.md) | [37.1](/filings/0001437749-26-014934.md) | [38.0](/filings/0001437749-26-026609.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(323) d](/filings/0001437749-24-034232.md) | [177 d](/filings/0001437749-25-008584.md) | [411](/filings/0001437749-25-015162.md) | [3,199 d](/filings/0001437749-25-025765.md) | [342 d](/filings/0001437749-25-033887.md) | [(579) d](/filings/0001437749-26-009091.md) | [(982)](/filings/0001437749-26-014934.md) | [3,034 d](/filings/0001437749-26-026609.md) | [1,453 d](/filings/0001437749-25-033887.md) | [278 d](/filings/0001437749-26-009091.md) | [(1,258)](/filings/0001437749-26-014934.md) | [3,011 d](/filings/0001437749-26-026609.md) |
| Capital expenditure | $k | [1,001 d](/filings/0001437749-24-034232.md) | [686 d](/filings/0001437749-25-008584.md) | [355](/filings/0001437749-25-015162.md) | [348 d](/filings/0001437749-25-025765.md) | [1,002 d](/filings/0001437749-25-033887.md) | [548 d](/filings/0001437749-26-009091.md) | [390](/filings/0001437749-26-014934.md) | [292 d](/filings/0001437749-26-026609.md) | [601 d](/filings/0001437749-25-033887.md) | [444 d](/filings/0001437749-26-009091.md) | [525](/filings/0001437749-26-014934.md) | [640 d](/filings/0001437749-26-026609.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,875](/filings/0001437749-21-012110.md) | [3,875](/filings/0001437749-21-018949.md) | [3,875](/filings/0001437749-21-026259.md) | [3,945](/filings/0001437749-22-012173.md) | [3,929](/filings/0001437749-22-020392.md) | [3,931](/filings/0001437749-22-026962.md) | [3,899](/filings/0001437749-23-013661.md) | [3,922](/filings/0001437749-23-023360.md) | [3,919](/filings/0001437749-23-031315.md) | [3,899](/filings/0001437749-23-013661.md) | [3,899](/filings/0001437749-23-023360.md) | [3,899](/filings/0001437749-23-031315.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,287,647 at 2026-05-05, from the cover of the [10-Q filed 2026-05-05](/filings/0001437749-26-014934.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.